Structure | Chemical Name | CAS | MF |
|
N-(p-Vinylbenzyl)-N-[2-(trimethoxysilyl)propyl]ethylenediamine
|
|
C17H30N2O3Si
|
|
N-(p-Vinylbenzyl)-N-(trimethoxysilylpropyl)ethylenediamine salt
|
|
|
|
N-[(R)-2-[3,4-Bis[(trimethylsilyl)oxy]phenyl]-2-[(trimethylsilyl)oxy]ethyl]-N,α,α,α-tetramethylsilanamine
|
55429-87-3
|
C21H45NO3Si4
|
|
N-[(R)-3-Carbamoyl-2-hydroxypropyl]trimethylaminium
|
|
C7H17N2O2+
|
|
(-)-N-[(R)-α-Carbamoylbenzyl]benzamide
|
|
|
|
NR2B NMDA receptor
|
|
|
|
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-furo[2,3-
c]pyridine- 5-carboxamide
hydrochloride PHA 543613
hydrochloride
|
478149-53-0
|
C15H17N3O2
|
|
N-[(8R)-1-azabicyclo[2.2.2]oct-8-yl]-2-oxo-9-thia-5-azabicyclo[4.3.0]n ona-3,7,10-triene-3-carboxamide hydrochloride
|
194093-42-0
|
C15H18ClN3O2S
|
|
N-(3R)-1-AZABICYCLO[2.2.2]OCT-3-YL-4-CHLOROBENZAMIDE
|
123464-89-1
|
C14H17ClN2O
|
|
N-(3R)-1-AZABICYCLO[2.2.2]OCT-3-YL-4-CHLORO-BENZAMIDE MONOHYDROCHLORIDE HYDRATE
|
|
C14H20Cl2N2O2
|
|
N-(3R)-1-AZABICYCLO[2.2.2]OCT-3-YL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-CARBOXAMIDE FUMARATE
|
527680-56-4
|
C16H20N2O3
|
|
Nr-cell adhesion molecule
|
139381-29-6
|
|
|
N-[[(2R)-Azetidin-2-yl]carbonyl]-L-Leu-Gly-NH2
|
|
|
|
NRBP protein
|
|
|
|
NRD
|
|
|
|
N-[2-[[(3R)-1-[(4-chlorophenyl)methyl]-3-pyrrolidinyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamidehydrochloride
|
226226-39-7
|
C21H21ClF3N3O2
|
|
N-[(R)-1-(2-Chloro-acetyl)-piperidin-3-yl]-N-cyclopropyl-acetaMide
|
1354006-77-1
|
C12H19ClN2O2
|
|
N-[(R)-1-(2-Chloro-acetyl)-piperidin-3-yl]-N-ethyl-acetaMide
|
1354003-42-1
|
C11H19ClN2O2
|
|
N-[(R)-1-(2-Chloro-acetyl)-piperidin-3-yl]-acetaMide
|
1354008-10-8
|
C9H15ClN2O2
|
|
N-[(R)-1-(2-Chloro-acetyl)-piperidin-3-yl]-N-Methyl-acetaMide
|
1354019-85-4
|
C10H17ClN2O2
|
|
N-[(R)-1-(2-Chloro-acetyl)-pyrrolidin-3-yl]-N-Methyl-acetaMide
|
1354001-45-8
|
C9H15ClN2O2
|
|
N-[(R)-1-(2-Chloro-acetyl)-pyrrolidin-3-yl]-N-ethyl-acetaMide
|
1354003-43-2
|
C10H17ClN2O2
|
|
N-[(R)-1-(2-Chloro-acetyl)-pyrrolidin-3-yl]-N-isopropyl-acetaMide
|
1354016-35-5
|
C11H19ClN2O2
|
|
N-[(R)-1-(2-Chloro-acetyl)-piperidin-3-yl]-N-isopropyl-acetaMide
|
1354001-49-2
|
C12H21ClN2O2
|
|
N-[(R)-1-(2-Chloro-acetyl)-pyrrolidin-3-yl]-N-cyclopropyl-acetaMide
|
1354016-43-5
|
C11H17ClN2O2
|
|
N-[(R)-1-(2-Chloro-acetyl)-pyrrolidin-3-yl]-acetaMide
|
1107645-70-4
|
C8H13ClN2O2
|
|
N-[(R)-(4-chlorophenyl)phenylMethyl]ForMaMide
|
474654-18-7
|
C14H12ClNO
|
|
N-[(R)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]acetamide
|
|
C19H29ClN2O3
|
|
N-[(R)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]-4-hydroxybenzeneacetamide
|
|
C25H33ClN2O4
|
|
N-[(R)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]-1H-indole-3-acetamide
|
|
C27H34ClN3O3
|
|
(+)-N-[(R)-2-Chloropropionyl]glycine
|
|
C5H8ClNO3
|
|
(+)-N-[(R)-3-Chloro-1-methyl-2-oxopropyl]phthalimide
|
|
C12H10ClNO3
|
|
(+)-N-[(R)-6-Chloro-3-methylhexyl]acetamide
|
|
C9H18ClNO
|
|
N-[(R)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]-3-(methylthio)propanamide
|
|
C21H33ClN2O3S
|
|
(+)-2-[N-[(R)-2-Chloropropionyl]amino]benzoic acid
|
|
C10H10ClNO3
|
|
N-(2-{4-[(1R)-2-chloro-1-hydroxyethyl]phenyl}ethyl)methanesulfonamide
|
|
C11H16ClNO3S
|
|
N-{4-[(1R)-2-chloro-1-hydroxyethyl]phenyl}-N-ethylmethanesulfonamide
|
|
C11H16ClNO3S
|
|
N-[(3R)-3-(4-chlorophenyl)-3-(2-pyridyl)propyl]-N,N-dimethylamine fumarate
|
|
C20H23ClN2O4
|
|
N-{4-[(1R)-2-chloro-1-hydroxyethyl]phenyl}-N-methylmethanesulfonamide
|
|
C10H14ClNO3S
|
|
N-{4-[(1R)-2-chloro-1-hydroxyethyl]phenyl}methanesulfonamide
|
|
C9H12ClNO3S
|
|
N-[(R)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]benzeneacetamide
|
|
C25H33ClN2O3
|
|
(-)-N-[(R)-2-Chloro-1-methylethyl]-N-methylformamide
|
|
C5H10ClNO
|
|
(+)-N-[(R)-2-Bromohexanoyl]glycine
|
|
C8H14BrNO3
|
|
(+)-N-[(R)-3-Bromo-1-methyl-2-oxopropyl]phthalimide
|
|
C12H10BrNO3
|
|
(+)-N-[(R)-α-Bromohydrocinnamoyl]glycine
|
|
|
|
(+)-N-[(R)-2-Bromo-3-methylbutyryl]glycine
|
|
C7H12BrNO3
|
|
(+)-N-[(R)-2-Bromopropionyl]glycine
|
|
C5H8BrNO3
|
|
Nα-[(2R)-3-(5-Bromo-1H-indol-3-yl)-2-aminopropionyl]-L-tryptophan
|
|
|
|
(-)-N-[(R)-α-(Bromomethyl)benzyl]acetamide
|
|
|
|
(+)-N-[(R)-α-(Bromoacetyl)-p-methoxyphenethyl]phthalimide
|
|
|
|
N-[(2R)-1-Bromohexan-2-yl]acetamide
|
|
C8H16BrNO
|
|
(+)-N-[(R)-2-Bromo-4-methylvaleryl]glycine
|
|
C8H14BrNO3
|
|
N-[(9R)-cinchonan-9-yl]-3,5-bis(trifluoroMethyl)-BenzenesulfonaMide
|
|
C27H25F6N3O2S
|
|
N-(9R)-cinchonan-9-yl-N'-[(2S)-2-pyrrolidinylMethyl]-Thiourea
|
1222966-36-0
|
C25H33N5S
|
|
N-(9R)-cinchonan-9-yl-N'-[(2R)-2-pyrrolidinylMethyl]-Thiourea
|
1222966-44-0
|
C25H33N5S
|
|
NRDC108
|
18877-89-9
|
C20H24O3
|
|
NRDC 157
|
82691-18-7
|
C21H20Br2O3
|
|
N-[[(2R)-1-Butyl-2-pyrrolidinyl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
C17H27N3O4S
|
|
N-[(R)-Butan-2-yl]adenosine
|
|
C14H21N5O4
|
|
N-[[(2R)-1-Decylpyrrolidin-2β-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
|
|
NR2C NMDA receptor
|
|
|
|
NrdD protein, Alcaligenes
|
|
|
|
NrdD protein
|
|
|
|
NrdF protein
|
|
|
|
Npw38 protein
|
|
|
|
NrdG protein, Alcaligenes
|
|
|
|
nrdG protein
|
|
|
|
NPY(28-36)
|
|
|
|
(-)-N-[(R)-4-Diazo-2-methyl-3-oxobutyl]phthalimide
|
|
C13H11N3O3
|
|
3-N'-[(R)-2,4-Diaminobutyryl]amphotericin B methyl ester
|
|
|
|
3-N'-[(R)-2,4-Diaminobutyryl]amphotericin B2-propynyl ester
|
|
|
|
(+)-N-[(R)-6-Diazo-3-methyl-5-oxohexyl]phthalimide
|
|
C15H15N3O3
|
|
(+)-N-[(R)-3-Diazo-1-methyl-2-oxopropyl]phthalimide
|
|
C12H9N3O3
|
|
3-N'-[(R)-3,6-Diaminohexanoyl]amphotericin B methyl ester
|
|
|
|
(+)-N-[(R)-α-Diazoacetyl-p-methoxyphenethyl]phthalimide
|
|
|
|
(-)-N-[(R)-4-Diazo-1-methyl-3-oxobutyl]phthalimide
|
|
C13H11N3O3
|
|
(-)-N-[(R)-5-Diazo-3-methyl-4-oxopentyl]phthalimide
|
|
C14H13N3O3
|
|
(+)-N-[(R)-1,2-Dicyclohexylethyl]maleimide
|
|
C18H27NO2
|
|
(+)-N-[(R)-1,2-Dicyclohexylethyl]-2-methylenesuccinimide
|
|
C19H29NO2
|
|
(+)-N-[(R)-1,2-Di(cyclohexyl)ethyl]phthalimide
|
|
C22H29NO2
|
|
(+)-N-[(R)-α-Diethoxymethyl-p-methoxyphenethyl]phthalimide
|
|
|
|
(+)-N-[(R)-1,1-Diethoxypropane-2-yl]phthalimide
|
|
C15H19NO4
|
|
N-[(2R)-2-(2,4-Difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl]-4-chlorobenzamide
|
|
C18H15ClF2N4O2
|
|
NrdH protein
|
|
|
|
N-[(2R)-2,4-Dihydroxy-3,3-diMethyl-1-oxobutyl]-
|
356786-94-2
|
C9H16CaNO5+
|
|
(-)-N-[(R)-3,β-Dihydroxyphenethyl]-N-methylacetamide
|
|
|
|
N-[[[(2R)-2,5-Dihydro-5β-isopropyl-3,6-dimethoxy-2-allylpyrazin]-2α-yl]methyl]-2,2-dimethylpropanamide
|
|
|
|
(-)-N-[(R)-β,3-Dihydroxy-4-nitrophenethyl]-N-methylacetamide
|
|
|
|
N-[[[(2R)-2,5-Dihydro-5β-isopropyl-3,6-dimethoxy-2-allylpyrazin]-2α-yl]methyl]-2-phenylacetamide
|
|
|
|
N-[2-[(2R)-5α-[3,4-Dihydro-5-(hydroxymethyl)-2,4-dioxopyrimidin-1(2H)-yl]tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-glutamic acid
|
89156-91-2
|
C26H34N6O14
|
|
N-[[[(2R)-2,5-Dihydro-5β-isopropyl-3,6-dimethoxy-2-benzylpyrazin]-2α-yl]methyl]-2,2-dimethylpropanamide
|
|
|
|
N-[[[(2R)-2,5-Dihydro-5β-isopropyl-3,6-dimethoxy-2-methylpyrazin]-2α-yl]methyl]-2,2-dimethylpropanamide
|
|
|
|
N-[2-[(2R)-5α-(3,4-Dihydro-5-methyl-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-glutamic acid
|
89156-90-1
|
C26H34N6O13
|
|
N-[(R)-3,4-Dihydro-8-hydroxy-3α-methyl-1-oxo-1H-2-benzopyran-7-yl]carbonyl-L-phenylalanine ethyl ester
|
18420-71-8
|
C22H23NO6
|
|
N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine
|
95259-50-0
|
C24H32N6O12
|
|
N-[[(R)-2,3-Dihydro-5-butoxy-1H-inden]-1α-yl]adenosine
|
|
|
|
N-[[[(2R)-2,5-Dihydro-5β-isopropyl-3,6-dimethoxy-2-benzylpyrazin]-2α-yl]methyl]-2-phenylacetamide
|
|
|
|
N-[(R)-2,4-Dihydroxy-3,3-dimethyl-1-oxobutyl]-β-alanine anion
|
|
|
|
N-[[[(2R)-2,5-Dihydro-5β-isopropyl-3,6-dimethoxy-2-methylpyrazin]-2α-yl]methyl]-2-phenylacetamide
|
|
|
|
N-[[(R)-2,3-Dihydro-5-methoxy-1H-inden]-1α-yl]adenosine
|
|
|